Hemodynamic Evidence of Vascular Remodeling in Combined Post- and Precapillary Pulmonary Hypertension

Although commonly encountered, patients with combined postcapillary and precapillary pulmonary hypertension (Cpc-PH) have poorly understood pulmonary vascular properties. The product of pulmonary vascular resistance and compliance, resistance-compliance (RC) time, is a measure of pulmonary vascular physiology. While RC time is lower in postcapillary PH than in precapillary PH, the RC time in Cpc-PH and the effect of pulmonary wedge pressure (PWP) on RC time are unknown. We tested the hypothesis that Cpc-PH has an RC time that resembles that in pulmonary arterial hypertension (PAH) more than that in isolated postcapillary PH (Ipc-PH). We analyzed the hemodynamics of 282 consecutive patients with PH referred for right heart catheterization (RHC) with a fluid challenge from 2004 to 2013 (cohort A) and 4,382 patients who underwent RHC between 1998 and 2014 for validation (cohort B). Baseline RC time in Cpc-PH was higher than that in Ipc-PH and lower than that in PAH in both cohorts (P < 0.001). In cohort A, RC time decreased after fluid challenge in patients with Ipc-PH but not in those with PAH or Cpc-PH (P < 0.001). In cohort B, the inverse relationship of pulmonary vascular compliance and resistance, as well as that of RC time and PWP, in Cpc-PH was similar to that in PAH and distinct from that in Ipc-PH. Our findings demonstrate that patients with Cpc-PH have pulmonary vascular physiology that resembles that of patients with PAH more than that of Ipc-PH patients. Further study is warranted to identify determinants of vascular remodeling and assess therapeutic response in this subset of PH.

[1]  E. Brittain,et al.  Integration of Complex Data Sources to Provide Biologic Insight into Pulmonary Vascular Disease (2015 Grover Conference Series) , 2016, Pulmonary circulation.

[2]  G. Grunwald,et al.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program , 2016, Circulation.

[3]  J. Jakowitsch,et al.  Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival. , 2015, American journal of respiratory and critical care medicine.

[4]  D. Chemla,et al.  Pulmonary vascular resistance and compliance relationship in pulmonary hypertension , 2015, European Respiratory Journal.

[5]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[6]  J. Paulus,et al.  Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction. , 2015, JACC. Heart failure.

[7]  R. Naeije.  Measurement to predict survival: the case of diastolic pulmonary gradient. , 2015, JACC. Heart failure.

[8]  J. Newman,et al.  Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension. , 2015, Chest.

[9]  C. Hadinnapola,et al.  The resistance-compliance product of the pulmonary circulation varies in health and pulmonary vascular disease , 2015, Physiological reports.

[10]  V. Melenovský,et al.  Differential Hemodynamic Effects of Exercise and Volume Expansion in People With and Without Heart Failure , 2015, Circulation. Heart failure.

[11]  D. Aronson,et al.  Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension , 2015, European journal of heart failure.

[12]  R. Naeije,et al.  Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. , 2014, American journal of respiratory and critical care medicine.

[13]  R. Channick,et al.  Reliance on end-expiratory wedge pressure leads to misclassification of pulmonary hypertension , 2014, European Respiratory Journal.

[14]  R. Tedford.  Determinants of Right Ventricular Afterload (2013 Grover Conference Series) , 2014, Pulmonary circulation.

[15]  S. Ghio,et al.  Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure. , 2014, Chest.

[16]  J. Newman,et al.  High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension , 2014, Circulation. Heart failure.

[17]  F. Martinez,et al.  Pulmonary hypertension due to left heart diseases. , 2013, Journal of the American College of Cardiology.

[18]  N. Westerhof,et al.  Measuring central pulmonary pressures during exercise in COPD: how to cope with respiratory effects , 2013, European Respiratory Journal.

[19]  R. Naeije.  Physiology of the Pulmonary Circulation and the Right Heart , 2013, Current Hypertension Reports.

[20]  B. Borlaug,et al.  Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure. , 2013, JACC. Heart failure.

[21]  R. Naeije,et al.  Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension. , 2013, American journal of physiology. Heart and circulatory physiology.

[22]  Yuhui Zhang,et al.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. , 2013, Chest.

[23]  B. Levine,et al.  Hemodynamic Responses to Rapid Saline Loading: The Impact of Age, Sex, and Heart Failure , 2013, Circulation.

[24]  M. Hudson,et al.  High prevalence of occult left heart disease in scleroderma-pulmonary hypertension , 2012, European Respiratory Journal.

[25]  J. Lordan,et al.  Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. , 2012, American journal of respiratory and critical care medicine.

[26]  R. Naeije,et al.  The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease , 2012, European Respiratory Journal.

[27]  M. Humbert,et al.  Out-of-Proportion Pulmonary Hypertension and Heart Failure with Preserved Ejection Fraction , 2012, Respiration.

[28]  J. Torres-Macho,et al.  Predictors of pulmonary hypertension in patients with end-stage heart failure. , 2012, Congestive heart failure.

[29]  N. Ohte,et al.  Pulmonary hypertension in heart failure with preserved left ventricular ejection fraction: diagnosis and management , 2012, Current opinion in cardiology.

[30]  James O. Mudd,et al.  Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading , 2012, Circulation.

[31]  Gene Kim,et al.  Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. , 2012, American heart journal.

[32]  M. Yigla,et al.  Characterization of Pulmonary Venous Hypertension Patients with Reactive Pulmonary Hypertension as Compared to Proportional Pulmonary Hypertension , 2011, Respiration.

[33]  Sanjiv J. Shah,et al.  Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction , 2011, Circulation. Heart failure.

[34]  N. Westerhof,et al.  The arterial load in pulmonary hypertension , 2010, European Respiratory Review.

[35]  E. Clayton,et al.  Principles of Human Subjects Protections Applied in an Opt‐Out, De‐identified Biobank , 2010, Clinical and translational science.

[36]  B. Westerhof,et al.  RC time constant of single lung equals that of both lungs together: a study in chronic thromboembolic pulmonary hypertension. , 2009, American journal of physiology. Heart and circulatory physiology.

[37]  S. Halpern,et al.  Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. , 2009, Chest.

[38]  D. Roden,et al.  Development of a Large‐Scale De‐Identified DNA Biobank to Enable Personalized Medicine , 2008, Clinical pharmacology and therapeutics.

[39]  G. Raskob,et al.  Design of the REVEAL registry for US patients with pulmonary arterial hypertension. , 2008, Mayo Clinic proceedings.

[40]  Nico Westerhof,et al.  Pulmonary vascular resistance and compliance stay inversely related during treatment of pulmonary hypertension. , 2008, European heart journal.

[41]  Nico Westerhof,et al.  Quantification of right ventricular afterload in patients with and without pulmonary hypertension. , 2006, American journal of physiology. Heart and circulatory physiology.

[42]  Paul Sorajja,et al.  Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. , 2006, Journal of the American College of Cardiology.

[43]  F. López-Ríos,et al.  Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure , 2005, European journal of heart failure.

[44]  R. Naeije.  Pulmonary vascular resistance. A meaningless variable? , 2003, Intensive care medicine.

[45]  Y Lecarpentier,et al.  Pulmonary artery pulse pressure and wave reflection in chronic pulmonary thromboembolism and primary pulmonary hypertension. , 2001, Journal of the American College of Cardiology.

[46]  S. Reuben,et al.  Compliance of the Human Pulmonary Arterial System in Disease , 1971, Circulation research.

[47]  Simon Gibbs,et al.  [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.

[48]  M. Gatzoulis,et al.  [Updated clinical classification of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[49]  K. Lewis.  Pulmonary Arterial Hypertension in France: Results from a National Registry , 2007 .

[50]  R. Naeije.  Pulmonary vascular resistance , 2003 .

[51]  M. I. Ferrer,et al.  A reconsideration of the origins of pulmonary hypertension. , 1971, Chest.